Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (471)

1

Platinum-based chemotherapy in metastatic prostate cancer : what possibilities?

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Catalano, M. | Lapucci, A. | Nobili, S. | +7

2

Increase in serum creatinine levels after PARP inhibitor treatment

enthalten in: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology | 2023

von You, D. | Zhong, L. | Yin, R. | +1

3

The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489

enthalten in: Cells | 2023

von Soung, Y. | Ju, J. | Chung, J.

4

PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition

enthalten in: Cell reports. Medicine | 2023

von Li, Y. | Dobrolecki, L. | Sallas, C. | +21

5

Small molecule tractable PARP inhibitors : Scaffold construction approaches, mechanistic insights and structure activity relationship

enthalten in: Bioorganic chemistry | 2023

von Thakur, A. | Rana, M. | Ritika | +5

6

Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma

enthalten in: Molecular carcinogenesis | 2023

von Bitler, B. | Bailey, C. | Yamamoto, T. | +3

7

An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time

enthalten in: Cell reports. Medicine | 2023

von Lee, C. | Cheng, W. | Lin, P. | +6

8

Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins

enthalten in: Cell reports. Medicine | 2023

von McGrail, D. | Li, Y. | Smith, R. | +11

9

Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages

enthalten in: Cell reports | 2023

von Kim, H. | Aliar, K. | Tharmapalan, P. | +23

ErratumIn: Cell Rep. 2023 Oct 25;42(11):113382. - PMID 37883228

10

Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma

enthalten in: Cell reports | 2023

von Xu, Y. | Spear, S. | Ma, Y. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]